SFX by Ex Libris Inc.

Title:	Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling
Source:	Science [0036-8075] Sabatini, D M yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kim, Do-Hyung H. "mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery." Cell 110.2 (2002): 163-175.
description	2.	Panta, Ganesh R R. "ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage." Molecular and cellular biology 24.5 (2004): 1823-35.
description	3.	Hresko, Richard C C. "mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes." The Journal of biological chemistry 280.49 (2006): 40406-16.
description	4.	Kim, Do-Hyung H. "G beta L, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR." Molecular cell 11.4 (2003): 895-904.
description	5.	Viniegra, Juan Guinea G. "Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM." The Journal of biological chemistry 280.6 (2005): 4029-4036.
description	6.	Sabatini, David M M. "Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton." Current biology 14.14 (2004): 1296-1302.
description	7.	Laplante, M. "mTOR Signaling in Growth Control and Disease." Cell 149.2 (2012): 274-293.
description	8.	Hara, K. "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action." Cell 110.2 (2002): 177-189.
description	9.	Sarbassov, D.D. D. "Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB." Molecular cell 22.2 (2006): 159-168.
description	10.	Sarbassov, DOS D. "Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex." Science 307.5712 (2005): 1098-1101.
description	11.	Zhang, Y. "Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3." The Journal of biological chemistry 278.15 (2003): 12650-9.
description	12.	Britton S, Salles B, Calsou P;, S. "c-MYC protein is degraded in response to UV irradiation." Cell cycle 7.1 (2008): 63-70.
description	13.	Ali, Siraj M M. "Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site." The Journal of biological chemistry 280.20 (2005): 19445-8.
description	14.	Vander Haar, E. "Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40." Nature cell biology 9.3 (2007): 316-23.
description	15.	Bose, A. "The v-SNARE Vti1a regulates insulin-stimulated glucose transport and Acrp30 secretion in 3T3-L1 adipocytes." The Journal of biological chemistry 280.44 (2005): 36946-51.
description	16.	Zhou, H. "Current development of second generation of mTOR inhibitors as anticancer agents." 癌症 31.1 (2012): 8-18.
description	17.	Guertin, David A M. "An expanding role for mTOR in cancer." Trends in molecular medicine 11.8 (2005): 353-61.
description	18.	Wang, A T. "Identification of a novel partner of Duox - EFP1, a thioredoxin-related protein." The Journal of biological chemistry 278.46 (2005): 3096-3103.
description	19.	Mora, A. "Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart." FEBS letters 579.17 (2005): 3632-3638.
description	20.	Wullschleger, S. "TOR Signaling in Growth and Metabolism." Cell 127.3: 471-484.